KINSHASA, Democratic Republic of the Congo / RankWire.AI / – Health authorities in the Democratic Republic of the Congo began administering Ebola vaccinations in Kisangani on Thursday, launching a targeted campaign in the capital of Tshopo Province to protect frontline responders. The initiative prioritizes healthcare workers, emergency response teams, and individuals with direct contact with confirmed patients as the country confronts its deadliest recorded Ebola outbreak. Health Minister Samuel-Roger Kamba confirmed that the government deployed an initial supply of the Ervebo vaccine under a compassionate-use framework across impacted eastern provinces to safeguard essential personnel and help disrupt viral transmission chains.
Official epidemiological data indicates that the ongoing outbreak has spread across six eastern provinces, including Ituri, North Kivu, South Kivu, Tshopo, Haut-Uele, and Bas-Uele. Public health figures published by the Ministry of Public Health and Prevention show that the country has recorded 5,713 confirmed cases and 2,744 deaths. The current overall case fatality rate among confirmed patients stands at approximately 48%.
In response to the health emergency, international health agencies, including the World Health Organization, are providing support to local medical teams through logistics, laboratory testing, and vaccine deployment. Vaccine distribution is being carried out under a compassionate-use framework as researchers gather observational data on its effectiveness against the circulating viral strain. DR Congo has launched an Ebola vaccination campaign, with health workers intensifying ring-vaccination efforts around identified infection clusters to help halt the spread of the virus.
Health Ministry Focuses on Ervebo Vaccines for Kisangani Healthcare Personnel
Operational challenges are faced due to complicated regional infrastructure, ongoing security issues, and significant population movement across border districts. Kisangani has established cold-chain logistics to preserve the ultra-cold temperatures necessary for vaccine storage before distribution to remote health zones. The Ebola vaccination campaign is underway, supported by civil defense and community health workers conducting outreach efforts to enhance disease surveillance and reporting.
Collaboration between epidemiologists from the Africa Centres for Disease Control and Prevention and local response units focuses on monitoring adverse reactions and assessing immune responses among vaccinated populations. Authorities emphasized that early clinical detection, combined with isolation procedures and supportive treatment, remains vital for increasing patient survival chances. Additional vaccine shipments are scheduled to support regional distribution expansion across secondary health districts.
Strict Infection Control Measures Enforced at Treatment Facilities by Health Authorities
The national response teams continue expanding contact-tracing activities across urban and rural communities in the eastern region. Personal protective equipment, diagnostic reagents, and therapeutic supplies are being supplied to municipal health centers to bolster their preparedness. The government agencies reaffirm that comprehensive public health protocols will remain active until data shows sustained decline in viral transmission across all affected provinces.
Authorities urged local communities to cooperate fully with mobile vaccination units and to follow established sanitation guidelines. It is expected that increased immunization among high-risk groups will help stabilize infection rates in the upcoming weeks. Surveillance networks will stay alert, focusing on transportation hubs and border crossings to prevent further geographic spread.